| Anti-CD7 and anti-CD19 chimeric antigen receptor T cell therapy | GC-197 | Phase 2 Clinical | Gracell Biotechnologies (Shanghai) Co Ltd | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| CLL1/CD33/CD38/CD7 CAR-T cell therapy | | Phase 2 Clinical | Guangzhou Bio-Gene Technology Co Ltd | | Details |
| BEAM-201 | BEAM-201 | Phase 2 Clinical | Beam Therapeutics Inc | Leukemia, Lymphoid; Leukemia, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| SupCD7 CART cells therapy (Institute Of Hematology & Blood Diseases Hospital) | | Phase 2 Clinical | Institute Of Hematology & Blood Diseases Hospital | Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| CD7-specific CAR-T Cell therapy(Taihe Chunyu Biotechnology) | | Phase 2 Clinical | Hebei Tahoe Chunyu Biotechnology Co Ltd | Hematologic Neoplasms; Lymphoma; Lymphoma, T-Cell | Details |
| CD7 CAR-T cell therapy(The General Hospital Of Western Theater Command) | | Phase 2 Clinical | The General Hospital Of Western Theater Command | | Details |
| CD5/CD7-Specific CAR-T Cells therapy(Essen Biotech) | BAH246; BAH-246; EB-BH2026 | Phase 2 Clinical | Essen Biotech | Central Nervous System Diseases; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| Autologous and Donor-derived CD7 CAR-T Therapy(Beijing GoBroad Hospital) | | Phase 2 Clinical | Beijing GoBroad Hospital | Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| CD7-CAR-T Cells Therapy | CD7-CART01 | Phase 2 Clinical | Bambino Gesu Hospital And Research Institute | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| RD-13 | RD13-02; RD 13 02; RD-13; RD-13-01; CTD-401; CTD-402 | Phase 2 Clinical | Nanjing Bioheng Biotech Co Ltd | Anemia, Aplastic; Diabetes Mellitus, Type 1; Hematologic Diseases; Hematologic Neoplasms; Lymphoma, Extranodal NK-T-Cell; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| Humanized CD7 CAR-T cells | | Phase 2 Clinical | The First Affiliated Hospital Of Soochow University | | Details |
| Soficabtagene Geleucel | WU-CART-007 | Phase 2 Clinical | Wugen Inc | Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome | Details |
| SenL-T7 CAR T Cells (Hebei Senlang Biological) | Senl-T7; Senl-T-7; SENL-101 | Phase 2 Clinical | Hebei Senlang Biological Technology Co Ltd | Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T lymphoblastic lymphoma | Details |
| PA3-17 | PA3-17 | Phase 2 Clinical | Persongen Biotherapeutics (Suzhou) Co Ltd | Hematologic Neoplasms; Leukemia, T-Cell; Lymphoma; Lymphoma, T-Cell; T lymphoblastic lymphoma | Details |
| CD7 CAR-T cell therapy (Hebei Senlang Biotechnology) | | Phase 2 Clinical | Hebei Senlang Biological Technology Co Ltd | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| Anti-CD7 CAR T-cell therapy (Yake Biotechnology) | | Phase 2 Clinical | Shanghai YaKe Biotechnology Co Ltd | Anemia, Aplastic; Autoimmune Diseases; Bone Marrow Failure Disorders; Colitis, Ulcerative; Crohn Disease; Dermatomyositis; Hematologic Diseases; Leukemia; Leukemia, T-Cell; Lymphoma; Lymphoma, T-Cell; Neoplasms; Osteochondrodysplasias; Still's Disease, Adult-Onset | Details |
| CD7.CAR/28zeta CAR T cells | | Phase 1 Clinical | Baylor College Of Medicine | Angioimmunoblastic T-cell Lymphoma; Leukemia, Prolymphocytic; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome | Details |
| GC-027 | GC-027 | Phase 1 Clinical | Gracell Biotechnologies (Shanghai) Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| UTAA-07 | UTAA-07; UTAA07 | Phase 1 Clinical | Persongen Biotherapeutics (Suzhou) Co Ltd | | Details |
| JY-008 | JY008; JY-008 | Phase 1 Clinical | Institute Of Hematology & Blood Diseases Hospital | Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| Anti CD7 CAR-T cells therapy (Peking University People'S Hospital) | | Phase 1 Clinical | Peking University People'S Hospital | Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| QH-106 | QH106; QH-106 | Phase 1 Clinical | Anhui Provincial Hospital | | Details |
| Anti-human CD7 CAR-NK cell Therapy(Shanghai General Hospital) | | Phase 1 Clinical | Shanghai Jiao Tong University Affiliated First People'S Hospital | Hematologic Neoplasms; Immune System Diseases | Details |
| uCD7 CART cell therapy (Institute Of Hematology & Blood Diseases Hospital) | | Phase 1 Clinical | Institute Of Hematology & Blood Diseases Hospital | Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| VGO-Cs01p | VGO-Cs01p | Phase 1 Clinical | Shanghai Vitalgen BioPharma Co Ltd | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Details |
| MB-107(March Biosciences) | MB-107(March Biosciences) | Phase 1 Clinical | March Biosciences Inc | Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| Anti-CD7 Chimeric Antigen Receptor T-Cell therapy(Bioceltech Therapeutics) | BT-007 | Phase 1 Clinical | Bioceltech Therapeutics Ltd, Gracell Biotechnologies (Shanghai) Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| BE CAR-7 | BE-CAR-7 | Phase 1 Clinical | Great Ormond Street Hospital For Children Nhs Foundation Trust | Leukemia, Prolymphocytic, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| Anti-CD7 CAR-T cell Therapy (Shanghai Jiao Tong University Affiliated First People'S Hospital) | | Phase 1 Clinical | Shanghai Jiao Tong University Affiliated First People'S Hospital | Angioimmunoblastic T-cell Lymphoma; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| Anti-CD19/CD7 UCAR-T cell therapy (Gracell) | GC-502 | Phase 1 Clinical | Gracell Biotechnologies (Shanghai) Co Ltd | Lymphoma, Non-Hodgkin; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| CD7 CARvac T cell therapy (iCell Gene Therapeutics) | | Phase 1 Clinical | Icell Gene Therapeutics (Int'L) Ltd | Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
| PCART7-CD3 | PCART7-CD3 | Clinical | National University Of Singapore | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |
